Editorial
doi: 10.1111/tid.14014.
Epub 2023 Feb 3.
Preemptive therapy versus universal prophylaxis: Time for reconciliation?
Affiliations
- PMID: 36734636
- DOI: 10.1111/tid.14014
Item in Clipboard
Editorial
Preemptive therapy versus universal prophylaxis: Time for reconciliation?
Transpl Infect Dis.
2023 Apr.
No abstract available
Similar articles
-
Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.Clin Infect Dis. 2001 Mar 1;32(5):742-51. doi: 10.1086/319225. Epub 2001 Feb 20. Clin Infect Dis. 2001. PMID: 11229841 Review.
-
[Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].Rev Invest Clin. 2002 May-Jun;54(3):198-203. Rev Invest Clin. 2002. PMID: 12183888 Spanish.
-
Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance.Transplantation. 2010 Feb 15;89(3):320-6. doi: 10.1097/TP.0b013e3181bc0301. Transplantation. 2010. PMID: 20145523
-
High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy.J Infect Dis. 2002 Jan 1;185(1):20-7. doi: 10.1086/338143. Epub 2001 Dec 14. J Infect Dis. 2002. PMID: 11756977
-
Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapy.Am J Health Syst Pharm. 2006 Oct 1;63(19 Suppl 5):S10-6. doi: 10.2146/ajhp060378. Am J Health Syst Pharm. 2006. PMID: 16990639 Review.
Cited by
-
Management of cytomegalovirus infection after liver transplantation.World J Transplant. 2024 Sep 18;14(3):93209. doi: 10.5500/wjt.v14.i3.93209. World J Transplant. 2024. PMID: 39295968 Free PMC article. Review.
References
REFERENCES
-
- Singh N. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis. 2005;40(5):704-708. doi:10.1086/427506
-
- Kotton CN, Kumar D, Caliendo AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102(6):900-931. doi:10.1097/TP.0000000000002191
-
- Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13512. doi:10.1111/ctr.13512
-
- Singh N, Winston DJ, Razonable RR, et al. Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial. JAMA. 2020;323(14):1378-1387. doi:10.1001/jama.2020.3138
-
- Emery VC, Hassan-Walker AF, Burroughs AK, Griffiths PD. Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J Infect Dis. 2002;185(12):1723-1728. doi:10.1086/340653
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
